# Pralidoxime

## Pampara inj 500mg/20mL

##### 

| TAH Drug Code      | IPAM2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of muscle weakness and/or respiratory depression secondary to poisoning due to organophosphate anticholinesterase pesticides and chemicals (eg, nerve agents); control of overdose of anticholinesterase medications used to treat myasthenia gravis (ambenonium, neostigmine, pyridostigmine)                                                                                                                                                                                                                                                |
| Dosing             | (仿單) Loading dose 1 g IV; may repeat bolus of 1 g after 30 minutes if symptoms have not been relieved.                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | According to the manufacturer, relative contraindications include hypersensitivity to pralidoxime or any component of the formulation and other situations where the risk of administration clearly outweighs possible benefit.                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Cardiovascular: Cardiac arrest, hypertension, tachycardia Central nervous system: Dizziness, drowsiness, headache, paralysis, seizure Dermatologic: Skin rash Gastrointestinal: Nausea Hepatic: Increased serum ALT (transient), increased serum AST (transient) Local: Pain at injection site (IM) Neuromuscular & skeletal: Fasciculations, increased creatine phosphokinase, laryngospasm, muscle rigidity, weakness Ophthalmic: Accommodation disturbance, blurred vision, diplopia Renal: Renal insufficiency Respiratory: Apnea, hyperventilation |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

